Operating principles (2011-15)

in page functions
[French]

As a public-private partnership including civil society, the Vaccine Alliance plays a catalytic role providing funding to countries and demonstrates "added-value" by:

  1. advocating for immunisation in the context of a broader set of cost-effective public health interventions;
  2. contributing to achieving the Millennium Development Goals (MDGs);
  3. supporting national priorities, integrated delivery, budget processes and decision-making;
  4. focusing on innovation, efficiency, equity, performance and results;
  5. maximising cooperation and accountability among partners through the Secretariat;
  6. ensuring gender equity in all areas of engagement.

5 -> 16

From 5 to 16 vaccine manufacturers supplying Gavi – more than half based in Africa, Asia and Latin America.

2001: 5 vaccine manufacturers producing prequalified, appropriate Gavi vaccines – 1 based in Africa;
2015: 16 vaccine manufacturers producing prequalified, appropriate Gavi vaccines – 9 based in Africa, Asia and Latin America.

Gavi 2016

More facts...

close icon

modal window here